USCA RIA’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

USCA RIA’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.38M	Buy	24,975 +3,233	+15%	+$425K	0.21%	141
2021 Q1	$2.95M	Buy	21,742 +1,330	+7%	+$199K	0.19%	156
2020 Q4	$2.87M	Buy	20,412 +1,473	+8%	+$189K	0.2%	102
2020 Q3	$2.11M	Buy	18,939 +1,831	+11%	+$205K	0.17%	129
2020 Q2	$1.92M	Sell	17,108 -991	-5%	-$97.6K	0.17%	125
2020 Q1	$1.4M	Buy	18,099 +1,737	+11%	+$154K	0.16%	132
2019 Q4	$1.56M	Sell	16,362 -240	-1%	-$20.8K	0.14%	198
2019 Q3	$1.27M	Buy	16,602 +800	+5%	+$66.5K	0.12%	204
2019 Q2	$1.39M	Buy	15,802 +10,312	+188%	+$880K	0.14%	190
2019 Q1	$497K	Sell	5,490 -895	-14%	-$76.1K	0.05%	277
2018 Q4	$458K	Buy	6,385 +727	+13%	+$58.6K	0.06%	270
2018 Q3	$542K	Buy	5,658 +470	+9%	+$45.6K	0.06%	300
2018 Q2	$494K	Buy	5,188 +281	+6%	+$25.8K	0.05%	301
2018 Q1	$430K	Buy	+4,907	New	+$448K	0.05%	317

Other funds holding XBI

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

USCA RIA's XBI Position: Q2 2021 in Review

USCA RIA increased its State Street SPDR S&P Biotech ETF (XBI) stake by 15% in Q2 2021, buying an estimated $425K and bringing the position to 24,975 shares worth $3.38M. The position accounts for 0.21% of the portfolio, ranked #141.

USCA RIA first reported a position in XBI in Q1 2018 and has held it in 14 quarters since. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

USCA RIA held 24,975 shares of State Street SPDR S&P Biotech ETF worth $3.38M as of Q2 2021.
USCA RIA bought 3,233 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $425K.
State Street SPDR S&P Biotech ETF made up 0.21% of USCA RIA's portfolio in Q2 2021, its #141 holding.
USCA RIA first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 14 quarters since.
663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.